Testing has confirmed that a fourth undergraduate student has been infected in a meningococcal disease outbreak involving the less common serogroup B at the University of California at Santa Barbara (UCSB), according to a Dec 2 statement from the Santa Barbara County Public Health Department (SBCPHD). All four students were sickened within 3 weeks in November.
The United States has committed up to $5 billion for global efforts to fight AIDS, tuberculosis (TB), and malaria over the next 3 years, representing a $1 billion increase over the last 3-year pledge, said a PR Newswire release yesterday.
Global funding for the research and development (R&D) of new tuberculosis (TB) drugs, vaccines, and rapid diagnostic tests dropped 4.6% in 2012, to $627.4 million, after rising every year since 2005, according to a report from the New York–based Treatment Action Group (TAG), which focuses on AIDS and TB.
A rapid tuberculosis (TB) test that was endorsed by the World Health Organization (WHO) speeded the start of treatment but did not reduce TB-related illness in a field trial in four African countries, according to a study released yesterday in The Lancet.
Cases and deaths are down, but many cases go undetected and MDR-TB efforts are subpar, the agency said.
A vaccine targeting two common norovirus strains reduced vomiting and diarrhea and prevented severe illness in a small clinical challenge study, researchers reported today at the IDWeek conference in San Francisco.
The World Health Organization (WHO) and other health groups yesterday launched what they billed as the first global action plan to stop tuberculosis (TB) in children, saying it could save as many as 74,000 lives each year.
Saudi Arabia has reported three more Middle East Respiratory syndrome coronavirus (MERS-CoV) cases, according to a machine-translated Saudi government statement posted on disease-tracking Web sites.
Ten new polio cases have been confirmed in Pakistan's North Waziristan region, bringing to 25 the number of cases reported this year, Pakistan Today reported today.
Donald E. Low, MD, who became Canada's public face of SARS 10 years ago, died last night, according to media reports and Mount Sinai Hospital in Toronto, where he headed the microbiology department until recently.